Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Scientists have developed a blood test for Alzheimer’s disease that can help diagnose the neurodegenerative disease while ...

The new test could help identify which patients are most likely to benefit from new Alzheimer’s drugs. A newly developed ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

New blood test developed by researchers can not only detect Alzheimer’s disease but also determine its stage, helps ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

This article delves into the theoretical roles of these peptides in brain research and discusses the directions in which they ...